CRISPR/Cas9 deletion of SOX2 regulatory region 2 (SRR2) decreases SOX2 malignant activity in glioblastoma

1. Saenz-Antoñanzas, A.
2. Moncho-Amor, V.
3. Auzmendi-Iriarte, J.
4. Elua-Pinin, A.
5. Rizzoti, K.
6. Lovell-Badge, R.
7. Matheu, A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3390/CANCERS13071574 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus